Report

Global Artificial Intelligence in Drug Discovery Market Size study, by Component (Software, Services), by Technology (Machine Learning, Deep Learning, Others), by Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Others), by End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centres, Academic & Government Institutes) and Regional Forecasts 2020-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & forecasts, 2018-2027 (USD Billion)
1.2.1. Artificial Intelligence in Drug Discovery Market, by Region, 2018-2027 (USD Billion)
1.2.2. Artificial Intelligence in Drug Discovery Market, by Component, 2018-2027 (USD Billion)
1.2.3. Artificial Intelligence in Drug Discovery Market, by Technology, 2018-2027 (USD Billion)
1.2.4. Artificial Intelligence in Drug Discovery Market, by Application, 2018-2027 (USD Billion)
1.2.5. Artificial Intelligence in Drug Discovery Market, by End-Use, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Artificial Intelligence in Drug Discovery Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Artificial Intelligence in Drug Discovery Market Dynamics
3.1. Artificial Intelligence in Drug Discovery Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Artificial Intelligence in Drug Discovery Market: Industry Analysis
4.1. Porter's 5 force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Artificial Intelligence in Drug Discovery Market, by Component
5.1. Market Snapshot
5.2. Global Artificial Intelligence in Drug Discovery Market by Component, Performance - Potential Analysis
5.3. Global Artificial Intelligence in Drug Discovery Market Estimates & forecasts by Component 2017-2027 (USD Billion)
5.4. Artificial Intelligence in Drug Discovery Market, Sub Segment Analysis
5.4.1. Software
5.4.2. Services
Chapter 6. Global Artificial Intelligence in Drug Discovery Market, by Technology
6.1. Market Snapshot
6.2. Global Artificial Intelligence in Drug Discovery Market by Technology, Performance - Potential Analysis
6.3. Global Artificial Intelligence in Drug Discovery Market Estimates & forecasts by Technology 2017-2027 (USD Billion)
6.4. Artificial Intelligence in Drug Discovery Market, Sub Segment Analysis
6.4.1. Machine Learning
6.4.2. Deep Learning
6.4.3. Others
Chapter 7. Global Artificial Intelligence in Drug Discovery Market, by Application
7.1. Market Snapshot
7.2. Global Artificial Intelligence in Drug Discovery Market by Application, Performance - Potential Analysis
7.3. Global Artificial Intelligence in Drug Discovery Market Estimates & forecasts by Application 2017-2027 (USD Billion)
7.4. Artificial Intelligence in Drug Discovery Market, Sub Segment Analysis
7.4.1. Immuno-Oncology
7.4.2. Neurodegenerative Diseases
7.4.3. Cardiovascular Diseases
7.4.4. Others

Chapter 8. Global Artificial Intelligence in Drug Discovery Market, by End-Use
8.1. Market Snapshot
8.2. Global Artificial Intelligence in Drug Discovery Market by End-Use, Performance - Potential Analysis
8.3. Global Artificial Intelligence in Drug Discovery Market Estimates & forecasts by End-Use 2017-2027 (USD Billion)
8.4. Artificial Intelligence in Drug Discovery Market, Sub Segment Analysis
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Contract Research Organizations
8.4.3. Research Centres
8.4.4. Academic & Government Institutes

Chapter 9. Global Artificial Intelligence in Drug Discovery Market, Regional Analysis
9.1. Artificial Intelligence in Drug Discovery Market, Regional Market Snapshot
9.2. North America Artificial Intelligence in Drug Discovery Market
9.2.1. U.S. Artificial Intelligence in Drug Discovery Market
9.2.1.1. Component breakdown estimates & forecasts, 2017-2027
9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
9.2.1.3. Application breakdown estimates & forecasts, 2017-2027
9.2.1.4. End-Use breakdown estimates & forecasts, 2017-2027
9.2.2. Canada Artificial Intelligence in Drug Discovery Market
9.3. Europe Artificial Intelligence in Drug Discovery Market Snapshot
9.3.1. U.K. Artificial Intelligence in Drug Discovery Market
9.3.2. Germany Artificial Intelligence in Drug Discovery Market
9.3.3. France Artificial Intelligence in Drug Discovery Market
9.3.4. Spain Artificial Intelligence in Drug Discovery Market
9.3.5. Italy Artificial Intelligence in Drug Discovery Market
9.3.6. Rest of Europe Artificial Intelligence in Drug Discovery Market
9.4. Asia-Pacific Artificial Intelligence in Drug Discovery Market Snapshot
9.4.1. China Artificial Intelligence in Drug Discovery Market
9.4.2. India Artificial Intelligence in Drug Discovery Market
9.4.3. Japan Artificial Intelligence in Drug Discovery Market
9.4.4. Australia Artificial Intelligence in Drug Discovery Market
9.4.5. South Korea Artificial Intelligence in Drug Discovery Market
9.4.6. Rest of Asia Pacific Artificial Intelligence in Drug Discovery Market
9.5. Latin America Artificial Intelligence in Drug Discovery Market Snapshot
9.5.1. Brazil Artificial Intelligence in Drug Discovery Market
9.5.2. Mexico Artificial Intelligence in Drug Discovery Market
9.6. Rest of The World Artificial Intelligence in Drug Discovery Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. IBM Corporation
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Microsoft Corporation
10.2.3. Google LLC
10.2.4. NVIDIA Corporation
10.2.5. Atomwise, Inc.
10.2.6. Deep Genomics
10.2.7. Cloud Pharmaceuticals, Inc.
10.2.8. Insilico Medicine
10.2.9. BenevolentAI Limited
10.2.10. Exscientia Limited

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption